Levofloxacin Concomitant Versus Levofloxacin Sequential
ConditionHelicobacter Pylori Infection
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorDamascus Hospital
About this trial
The goal of this trial is to determine the efficacy of levofloxacin based sequential treatment regimen or concomitant levofloxacin based regimens as empirical first-line therapy in the Syrian population
Eligibility criteria
Qualifiers
Positive rapid urease test (CLOtest).
Histologic evidence of H. pylori by modified Giemsa staining.
Positive 13C-urea breath test. without prior eradication therapy and are willing to receive therapy.
Disqualifiers
Children and teenagers aged less than 18 years.
Previous eradication treatment for H. pylori.
Patients who took any drug, which could influence the study results such as proton pump inhibitor, H2 blocker, mucosal protective agent and antibiotics.
History of gastrectomy.
Trial design
Treatments tested in this trial
- sequential
- Levofloxacin 500Mg Oral Tablet
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov